0 results available. Select is focused ,type to refine list, press Down to open the menu,
iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company’s lead antibody pro...
The following section summarizes insights on Iteos Therapeutics Inc's Relative Strength Index (14d):
We've identified the following companies as similar to Iteos Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Relative Strength Index (14d) in the valuation category include:
A momentum oscillator that measures the speed and change of price movements.
No data available
The chart above depicts the distribution of relative strength index (14d) for companies operating in the Healthcare sector in the Developed economic region. Over 2,580 companies were considered in this analysis, and 2,535 had meaningful values. The average relative strength index (14d) of companies in the sector is 42.99 with a standard deviation of 16.29.
Iteos Therapeutics Inc's Relative Strength Index (14d) of 24.95 ranks in the 9.1% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,587 |
Included Constituents | 2,535 |
Min | 15.65 |
Max | 100.00 |
Median | 40.76 |
Mean | 42.99 |
Standard Deviation | 16.29 |
You can find companies with similar relative strength index (14d) using this stock screener.